Table 2.
CT and PET validity parameters versus histology (gold standard), using lymph nodes as the study unit.
A | Biopsy + | Biopsy − | Total |
| |||
CT + | 70 | 74 | 144 |
CT − | 9 | 50 | 59 |
Total | 79 | 124 | 203 |
PET + | 76 | 78 | 154 |
PET − | 4 | 45 | 49 |
Total | 80 | 123 | 203 |
| |||
B | Biopsy + | Biopsy − | Total |
PET + | 79 | 94 | 173 |
PET − | 0 | 30 | 30 |
Total | 79 | 124 | 203 |
| |||
C | CT | PET A | PET B |
S | 0.89 | 0.95 | 1 |
SP | 0.40 | 0.37 | 0.24 |
PPV | 0.49 | 0.49 | 0.46 |
NPV | 0.85 | 0.92 | 1 |
Percentage agreement and p | 0.207 (p < 0.001) | 0.241 (p < 0.001) | 0.189 (p < 0.001) |
(A) Preestablished cutoff points: positive CT if short axis ≥10 mm and positive PET if SUV >2.5. (B) ROC curve cutoff points: positive CT if short axis ≥2.5 mm and positive PET if SUV >0.5. (C) Sensitivity, specificity, predictive values, and percentage agreement for each PET cutoff point.